Subscribe to Newsletter

Content by Stephanie Vine:

Discovery & Development Formulation

Tackling the Nasal Membrane Challenge

| Stephanie Vine | 3 min read

Drugs are very challenging to formulate for delivery across the nasal membrane. An expert gives their view on the issue.

Business & Regulation Profession

Starting a Business in CRISPR

| Stephanie Vine | 8 min read

From a love of history books to a love of CRISPR, Monika Paule tells us the story of her career and the origins of Caszyme.

Manufacture Clinical Trials

This Week’s Biopharma News: AstraZeneca Cans Phase III Trial

| Stephanie Vine | 3 min read

Our latest news roundup reports on Amgen’s $900 million investment, EMA’s re-examination of donanemab, philanthropy at Sanofi, and more.

Manufacture Advanced Medicine

Inhalable Gene Therapies? Here’s How They Could Work

| Stephanie Vine | 5 min read

Scientists explain how inhalable gene therapies are being developed to treat cystic fibrosis.

Discovery & Development Clinical Trials

Trial Placed on FDA Clinical Hold for Testicular Toxicity

| Stephanie Vine | 1 min read

Non-clinical toxicology study of investigational drug for psoriasis reveals worrying results.

Manufacture Advanced Medicine

Kite, CAR Ts, and Access for Patients

| Stephanie Vine | 9 min read

We sat down with Kite’s Cindy Perettie to talk about access to CAR Ts.

Business & Regulation Profession

Medicine Making Pioneers

| Stephanie Vine

From Carl June to Peter Marks to Kiran Mazumdar-Shaw; check out our thought provoking interviews with some of the biggest names in the pharma field.

Discovery & Development Drug Discovery

The Golden Ticket For Obesity Drug Development

| Stephanie Vine | 6 min read

We speak to the 2025 winner of Novo Nordisk and Pioneer Group’s Golden Ticket program.

Manufacture Facilities

FUJIFILM Diosynth and Regeneron Sign 10-Year, $3 Billion Manufacturing Agreement

| Stephanie Vine | 2 min read

FUJIFILM Diosynth to manufacture biologics for Regeneron at new facility in Holly Springs, North Carolina.

Discovery & Development Dosage Forms

Going From Benchtop Chemist to CEO: Part 2

| Stephanie Vine | 5 min read

We speak with Colorcon CEO Simon Tasker about the importance of the patient experience when it comes to medicines.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker